TCR2 Therapeutics
+$0.00 (+0.03%) As of 3:29 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRR and other ETFs, options, and stocks.
About TCRR
TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It also involves in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development.
CEO
Garry E. Menzel
Employees
118
Headquarters
Cambridge, Massachusetts
Founded
2015
TCRR Key Statistics
Market cap
191.55M
Price-Earnings ratio
—
Dividend yield
—
Average volume
887.24K
High today
$5.14
Low today
$4.77
Open price
$5.01
Volume
132.94K
52 Week high
$35.86
52 Week low
$4.77
Analyst ratings
80%
of 10 ratings
Buy
80%
Hold
20%
Sell
0%
TCRR Earnings
-$0.69
-$0.46
-$0.23
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 10, Pre-Market